Aspen Aerogels Inc (ASPN) — 10-Q Filings
All 10-Q filings from Aspen Aerogels Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Aspen Aerogels Plunges to $316.6M Loss Amid Revenue Decline, Impairment
— Nov 6, 2025 Risk: high
Aspen Aerogels, Inc. reported a significant decline in financial performance for the nine months ended September 30, 2025, with revenue decreasing to $229.764 m -
Aspen Aerogels' Revenue Soars 36.5%, Narrows Q2 Net Loss
— Aug 7, 2025 Risk: medium
Aspen Aerogels Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $75.2 million, up from $55.1 million in the pr -
Aspen Aerogels Q1 2025 Update
— May 8, 2025 Risk: low
Aspen Aerogels Inc. reported its first quarter results for the period ending March 31, 2025. The company's filing details its financial position, including reta -
Aspen Aerogels Reports Q3 2024, Secures New Credit Facility
— Nov 7, 2024 Risk: medium
Aspen Aerogels Inc. reported its Q3 2024 results, ending September 30, 2024. The company entered into a Credit Security and Guaranty Agreement with Midcap Finan -
Aspen Aerogels Q2 Sales Hit $73.4M
— Aug 8, 2024 Risk: medium
Aspen Aerogels Inc. reported its Q2 2024 results, with net sales for the three months ended June 30, 2024, reaching $73.4 million. The company's operating segme -
Aspen Aerogels Reports Q1 2024 Results
— May 2, 2024 Risk: medium
ASPEN AEROGELS INC (ASPN) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Revenue for Q1 2024 was not explicitly stated, but the filing details rev
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX